Bluebird Bio earnings were -$240.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest BLUE earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$28.7M, down 52.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BLUE reported annual earnings of -$240.7M, with 13.6% growth. The next BLUE earnings date is May 7, 2025.
On BLUE's earnings call on Invalid Date, Bluebird Bio (NASDAQ: BLUE) reported Q4 2024 earnings per share (EPS) of -$2.84, up 79.7% year over year. Total BLUE earnings for the quarter were -$28.71 million. In the same quarter last year, Bluebird Bio's earnings per share (EPS) was -$13.99.
The next BLUE earnings call is Invalid Date. Add BLUE to your watchlist to be reminded of Bluebird Bio's next earnings date.
What was BLUE's earnings growth in the past year?
As of Bluebird Bio's earnings date in Invalid Date, Bluebird Bio's earnings has grown year over year. BLUE earnings in the past year totalled -$240.72 million.
Is Bluebird Bio profitable or losing money?
As of the last Bluebird Bio earnings report, Bluebird Bio is currently losing money. Bluebird Bio's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$240.72 million, a 13.59% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.